首页> 中文期刊> 《中国继续医学教育》 >瑞替普酶联合还原型谷胱甘肽治疗急性ST段抬高型心肌梗死疗效分析

瑞替普酶联合还原型谷胱甘肽治疗急性ST段抬高型心肌梗死疗效分析

         

摘要

ObjectiveTo analysis the effect of rPT and GSH on acute STEMI.MethodsFrom September 2013 to September 2014 clinical data of 104 cases of acute STEMI patients, were randomly divided into two groups, control group of 52 persons adopted rPT routine treatment, the observation group adopted rPT joint GSH treatment, compared two groups of blood vessels, myocardial enzyme index level and the rate of adverse reactions. ResultsAfter treatment the index level of myocardial enzyme of observation group were better than the control group, and the incidence of MACE, lower than the control group were statistical signiifcance (P<0.05). ConclusionThe rPT joint GSH is applied to the treatment of acute STEMI, can effectively improve the rate of blood vessels, improve ventricular structure and function.%目的:分析rPT联合GSH治疗急性STEMI疗效。方法分析我院2013年9月~2014年9月收治的104例急性STEMI患者临床资料,随机分为两组,对照组52例行rPT治疗,观察组行rPT联合GSH治疗,比较两组血管再通率、心肌酶指标水平及不良反应情况。结果治疗后观察组心肌酶各指标水平均优于对照组,且MACE发生率比对照组低,均具统计学意义(P<0.05)。结论 rPT联合GSH应用于急性STEMI的治疗,可有效提高血管再通率,改善心室结构及功能。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号